Hospitals in multiple states have adopted postpartum notification wristbands intended to improve recognition of post-delivery complications. While proponents cite increased awareness and lower readmission rates at some institutions, evidence supporting broad outcome benefits remains limited.

Maternal anti-HPA-1a antibodies inhibited β3 integrin activation in laboratory models, with stronger functional inhibition in severe FNAIT cases. The findings suggest a mechanism beyond platelet clearance, but clinical validation remains necessary.

Experts highlighted ongoing barriers and knowledge gaps affecting reproductive care for transgender and gender-diverse patients while outlining strategies to support pregnancy, postpartum care, and fertility discussions in affirming clinical environments.

A Georgia woman alleges that a pathology specimen mix-up led to an erroneous cancer diagnosis and an unnecessary hysterectomy. The lawsuit highlights the potential consequences of laboratory identification failures and diagnostic verification breakdowns.

Daily low-dose endoxifen reduced mammographic breast density versus placebo in premenopausal women, with fewer tolerability concerns at 1 mg. Whether this surrogate response translates into lower breast cancer incidence remains unknown.

A case report identified high-titer anti-RhD IgG antibodies in maternal breast milk as a potential source of ongoing hemolysis in an infant with persistent HDFN after exchange transfusion. The finding highlights a possible mechanism for delayed disease persistence but requires further validation.